рус
eng
Strategic consulting
Developing market access strategy Development of marketing strategy Portfolio assessment and development Registration dossier and market authorization
Ongoing analytical review of the Russian health care system
PharmСompass Russia PharmСompass Regions PharmCompass ЕАСU
Market research Pharmacoeconomic analysis Patient support programs
Clinical patient registries
Diabetes Mellitus Rheumatoid Arthritis (RA) Juvenile Arthritis Hemic Diseases Pituitary Tumours mRCC Diabetic Foot Syndrome Medullary Thyroid Cancer Diabetes Insipidus Other registries
Epidemiological studies Laboratory diagnostics programs Biostatistics Clinical trials Pharmacovigilance programs
BI solutions Quinta platform and Quinta solutions
Quinta Clinical Quinta Care Quinta Lab
Websites and educations web-portals Mobile apps Expert Systems
Analytical products
Aston 360 Report PharmСompass Russia Report PharmСompass Regions Report PharmCompass ЕEU
PharMon databases
PharMon Tenders PharMon Import
Expert Audit BI solutions
Exspertize » Therapeutic areas » Cardiology and CVD
Anastasia Zhigalkina

Cardiology and CVD

Aston Group has a wide experience in studying anticoagulant therapy, drugs used to improve heart function, angioprotectors and proofreaders microcirculation.

Among other research topics we have covered are pulmonary embolism, DVT, etc. Following the outcomes of a number of studies in this area, recommendations have been developed to justify introduction of the new cost-effective health technologies at the federal and regional level.

Our research in cardiology and cardiovascular disease is supported by valuable insights from health experts, procurement specialists and patient community.

 

Others therapeutic areas

CJSC Aston Consulting, 1999-2021
General Policy on Processing of Personal Data